Rita Rastogi Kalyani, MD, MHS, to Receive American Diabetes Association’s 2018 Vivian Fonseca and Nagendran Family Diabetes Research Award
June 14, 2018
Rita Rastogi Kalyani, MD, MHS, has been selected to receive the American Diabetes Association’s® (ADA’s) 2018 Vivian Fonseca and Nagendran Family Diabetes Research Award. The Vivian Fonseca and Nagendran Family Diabetes Research Award recognizes diabetes research focused on the South Asian, Asian American, Native Hawaiian and Pacific Islander populations, and/or research by a scientist from these areas, in memory of Mr. P. Nagendran. This award honors the contributions of Dr. Vivian Fonseca, a former President, Medicine & Science of the ADA; the Tullis-Tulane Alumni Chair in Diabetes; and Professor of Medicine Chief in the Section of Endocrinology at Tulane University School of Medicine, who has been a mentor and role model to many researchers and clinicians, and who continues to serve the ADA and the diabetes community in our quest for advances in diabetes care.
Dr. Kalyani will receive this honor during the ADA’s 78th Scientific Sessions, June 22-26, 2018, at the Orange County Convention Center in Orlando in recognition of her abstract, “The Relationship of Acculturation to Cardiometabolic Risk Factors among U.S. South Asians—Findings from the MASALA Study.” The abstract will also be the topic of her Vivian Fonseca and Nagendran Family Diabetes Research Award Lecture on Monday, June 25.
Dr. Kalyani is an Associate Professor of Medicine at The Johns Hopkins University School of Medicine in the Division of Endocrinology, Diabetes & Metabolism. She earned her undergraduate degree in neurobiology from Harvard College, then completed her medical degree, residency and an adult endocrinology fellowship at The Johns Hopkins University. Dr. Kalyani attends on both the inpatient endocrine consultation service and has an outpatient diabetes practice. She also directs the Diabetes Management Service for Johns Hopkins’ Total Pancreatectomy Islet Auto Transplant Program. Additionally, she is the Editor-in-Chief of the Johns Hopkins Diabetes POC-IT Guide mobile application for health care providers and The Johns Hopkins Patient Guide to Diabetes website.
An author of more than 100 peer-reviewed research publications, chapters and monographs, Dr. Kalyani is funded by the National Institutes of Health for her groundbreaking research investigating body composition and physical functioning in people with diabetes as they age, particularly among diverse populations. Dr. Kalyani is also a dedicated mentor of numerous faculty, fellows, residents and students. She lectures extensively and has served on the Editorial Board of Diabetes Care, including as Guest Editor for the theme issue on Diabetes and Aging in April 2017.
“Thank you, Dr. Kalyani, for your efforts on behalf of all people with diabetes. Your research accomplishments in the field of diabetes and aging set the stage for changing our approach to diabetes and the elderly,” said the ADA’s 2018 President of Medicine and Science Jane E.B. Reusch, MD. “Your innovative work has had an impressive impact on the lives of many people. Congratulations on this well-deserved honor.”
Dr. Kalyani is the Immediate Past Chair of the ADA’s Professional Practice Committee, responsible for the 2018 Standards of Medical Care in Diabetes, and currently serves as President of the ADA’s Maryland Community Leadership Board. Dr. Kalyani is actively involved in national education and diabetes awareness efforts and has developed international programs for the delivery of diabetes care in the Caribbean, Middle East and Asia.
The Vivian Fonseca and Nagendran Family Diabetes Research Award is given in memory of Mr. P. Nagendran and funded by a grant from Suku Nagendran, MD, and Anne Nagendran.
The American Diabetes Association’s 78th Scientific Sessions, to be held June 22-26, 2018, at the Orange County Convention Center in Orlando, is the world’s largest scientific meeting focused on diabetes research, prevention and care. During the five-day meeting, more than 16,000 health care professionals from around the world will have exclusive access to more than 3,000 original diabetes research presentations, participate in provocative and engaging exchanges with leading diabetes experts, and can earn Continuing Medical Education (CME) or Continuing Education (CE) credits for educational sessions. The program is grouped into eight theme areas: Acute and Chronic Complications; Behavioral Medicine, Clinical Nutrition, Education and Exercise; Clinical Diabetes/Therapeutics; Epidemiology/Genetics; Immunology/Transplantation; Insulin Action/Molecular Metabolism; Integrated Physiology/Obesity; and Islet Biology/Insulin Secretion. Felicia Hill-Briggs, PhD, ABPP, President of Health Care and Education, will deliver her address, “The American Diabetes Association in the Era of Health Care Transformation,” on Saturday, June 23, and Jane E.B. Reusch, MD, President of Medicine and Science, will present her address, “24/7/365 – Lifetime with Diabetes,” on Sunday, June 24. In total, the 2018 Scientific Sessions includes 375 oral presentations; 2,117 poster presentations, including 47 moderated poster discussions; and 297 published-only abstracts. Join the Scientific Sessions conversation on social media using #2018ADA.
About the American Diabetes Association
Nearly half of American adults have diabetes or prediabetes; more than 30 million adults and children have diabetes; and every 21 seconds, another individual is diagnosed with diabetes in the U.S. Founded in 1940, the American Diabetes Association (ADA) is the nation’s leading voluntary health organization whose mission is to prevent and cure diabetes, and to improve the lives of all people affected by diabetes. The ADA drives discovery by funding research to treat, manage and prevent all types of diabetes, as well as to search for cures; raises voice to the urgency of the diabetes epidemic; and works to safeguard policies and programs that protect people with diabetes. In addition, the ADA supports people living with diabetes, those at risk of developing diabetes, and the health care professionals who serve them through information and programs that can improve health outcomes and quality of life. For more information, please call the ADA at 1-800-DIABETES (1-800-342-2383) or visit diabetes.org. Information from both of these sources is available in English and Spanish. Find us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn)